vision loss tirzepatide Comparative ocular outcomes of versus other anti-obesity medications in people with obesity Vision loss: GLP-1 drugs like

Fu SC, Cheuk YC, Chiu WY, Yung SH, Rolf CG, Chan KM

However, the long-term cardiovascular and renal benefits need to be carefully evaluated against the risk of DKA

A more gradual approach may be recommended if you: Have experienced nausea with GLP-1 medications before Are sensitive to appetite suppressants Have a history of digestive issues Prefer a gentler adjustment period In these cases, remaining on the starting dose longer, or increasing in smaller steps, can significantly improve comfort

396,397,398,399 GLP-1RAs and nerve cells GLP-1 can modulate peripheral nerves through the ERK (extracellular signal-regulated kinase) signaling pathway, reducing the occurrence of neurological dysfunction

Thank you for trusting us to build the infrastructure your brand deserves

Obesity 2023;31:96110